FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164363535> ?p ?o ?g. }

• W2164363535 endingPage "934" @default.
• W2164363535 startingPage "927" @default.
• W2164363535 abstract "Arterial hypertension (HT) has been reported in all studies involving bevacizumab, an antiangiogenic agent designed to target vascular endothelial growth factor (VEGF). The mechanism underlying bevacizumab-related HT is not yet clearly understood. As far as endothelial dysfunction and microvascular rarefaction are hallmarks in all forms of HT, we tested the hypothesis that anti-VEGF therapy could alter the microcirculation in nontumor tissues and, thus, result in an increase in blood pressure (BP). We used intravital video microscopy to measure dermal capillary densities in the dorsum of the fingers. Microvascular endothelial function was assessed by laser Doppler flowmetry combined with iontophoresis of pilocarpine (acetylcholine analogue). All measurements were carried out in 18 patients before and after a 6-month treatment with bevacizumab (mean cumulative dose: 3.16 +/- 0.90 g). Mean BP was increased after 6 months of therapy compared with baseline, from 129 +/- 13/75 +/- 7 mmHg to 145 +/- 17/82 +/- 7 mmHg for systolic BP and diastolic BP, respectively (P < 0.0001). Compared with the baseline, mean dermal capillary density at 6 months was significantly lower (75 +/- 12 versus 83 +/- 13/mm(2); P < 0.0001), as well as pilocarpine-induced vasodilation (P < 0.05). Thus, bevacizumab treatment resulted in endothelial dysfunction and capillary rarefaction; both changes are closely associated and could be responsible for the rise in BP observed in most patients." @default.
• W2164363535 created "2016-06-24" @default.
• W2164363535 creator A5026377797 @default.
• W2164363535 creator A5027770003 @default.
• W2164363535 creator A5054993854 @default.
• W2164363535 creator A5068568995 @default.
• W2164363535 date "2008-05-01" @default.
• W2164363535 modified "2023-10-02" @default.
• W2164363535 title "Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation" @default.
• W2164363535 cites W1923133386 @default.
• W2164363535 cites W1968719918 @default.
• W2164363535 cites W1976439756 @default.
• W2164363535 cites W2004580984 @default.
• W2164363535 cites W2009029293 @default.
• W2164363535 cites W2010321363 @default.
• W2164363535 cites W2011470732 @default.
• W2164363535 cites W2020423449 @default.
• W2164363535 cites W2023128560 @default.
• W2164363535 cites W2024328965 @default.
• W2164363535 cites W2041034845 @default.
• W2164363535 cites W2046507292 @default.
• W2164363535 cites W2047141305 @default.
• W2164363535 cites W2048685924 @default.
• W2164363535 cites W2048818094 @default.
• W2164363535 cites W2056802932 @default.
• W2164363535 cites W2064116161 @default.
• W2164363535 cites W2070966641 @default.
• W2164363535 cites W2087221897 @default.
• W2164363535 cites W2089549133 @default.
• W2164363535 cites W2090458427 @default.
• W2164363535 cites W2091076176 @default.
• W2164363535 cites W2091774189 @default.
• W2164363535 cites W2102131871 @default.
• W2164363535 cites W2103227975 @default.
• W2164363535 cites W2110564525 @default.
• W2164363535 cites W2112267108 @default.
• W2164363535 cites W2114159573 @default.
• W2164363535 cites W2123421036 @default.
• W2164363535 cites W2125690417 @default.
• W2164363535 cites W2133302418 @default.
• W2164363535 cites W2142108077 @default.
• W2164363535 cites W2148333267 @default.
• W2164363535 cites W2148981209 @default.
• W2164363535 cites W2150216446 @default.
• W2164363535 cites W2157027198 @default.
• W2164363535 cites W2157769714 @default.
• W2164363535 cites W2164886552 @default.
• W2164363535 cites W2166271687 @default.
• W2164363535 cites W2171085327 @default.
• W2164363535 cites W2331201327 @default.
• W2164363535 cites W2531915439 @default.
• W2164363535 cites W74687677 @default.
• W2164363535 doi "https://doi.org/10.1093/annonc/mdm550" @default.
• W2164363535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18056916" @default.
• W2164363535 hasPublicationYear "2008" @default.
• W2164363535 type Work @default.
• W2164363535 sameAs 2164363535 @default.
• W2164363535 citedByCount "258" @default.
• W2164363535 countsByYear W21643635352012 @default.
• W2164363535 countsByYear W21643635352013 @default.
• W2164363535 countsByYear W21643635352014 @default.
• W2164363535 countsByYear W21643635352015 @default.
• W2164363535 countsByYear W21643635352016 @default.
• W2164363535 countsByYear W21643635352017 @default.
• W2164363535 countsByYear W21643635352018 @default.
• W2164363535 countsByYear W21643635352019 @default.
• W2164363535 countsByYear W21643635352020 @default.
• W2164363535 countsByYear W21643635352021 @default.
• W2164363535 countsByYear W21643635352022 @default.
• W2164363535 countsByYear W21643635352023 @default.
• W2164363535 crossrefType "journal-article" @default.
• W2164363535 hasAuthorship W2164363535A5026377797 @default.
• W2164363535 hasAuthorship W2164363535A5027770003 @default.
• W2164363535 hasAuthorship W2164363535A5054993854 @default.
• W2164363535 hasAuthorship W2164363535A5068568995 @default.
• W2164363535 hasBestOaLocation W21643635351 @default.
• W2164363535 hasConcept C118552586 @default.
• W2164363535 hasConcept C120770815 @default.
• W2164363535 hasConcept C126322002 @default.
• W2164363535 hasConcept C12722491 @default.
• W2164363535 hasConcept C134018914 @default.
• W2164363535 hasConcept C164705383 @default.
• W2164363535 hasConcept C167734588 @default.
• W2164363535 hasConcept C2776694085 @default.
• W2164363535 hasConcept C2776992346 @default.
• W2164363535 hasConcept C2777025900 @default.
• W2164363535 hasConcept C2777204577 @default.
• W2164363535 hasConcept C2777802072 @default.
• W2164363535 hasConcept C2778186239 @default.
• W2164363535 hasConcept C2780394083 @default.
• W2164363535 hasConcept C2780972559 @default.
• W2164363535 hasConcept C71924100 @default.
• W2164363535 hasConcept C84393581 @default.
• W2164363535 hasConceptScore W2164363535C118552586 @default.
• W2164363535 hasConceptScore W2164363535C120770815 @default.
• W2164363535 hasConceptScore W2164363535C126322002 @default.
• W2164363535 hasConceptScore W2164363535C12722491 @default.
• W2164363535 hasConceptScore W2164363535C134018914 @default.

• next